BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33107153)

  • 1. Nodal disease burden and outcome of medullary thyroid carcinoma.
    Moses LE; Oliver JR; Rotsides JM; Shao Q; Patel KN; Morris LGT; Givi B
    Head Neck; 2021 Feb; 43(2):577-584. PubMed ID: 33107153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer.
    Machens A; Lorenz K; Dralle H
    Br J Surg; 2019 Mar; 106(4):412-418. PubMed ID: 30725475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology.
    Machens A; Dralle H
    Eur J Surg Oncol; 2015 Jun; 41(6):766-72. PubMed ID: 25468749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
    Leggett MD; Chen SL; Schneider PD; Martinez SR
    Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factors for Lateral Lymph Node Metastases in Patients With Sporadic Medullary Thyroid Carcinoma.
    Wu X; Li B; Zheng C; Liu W; Hong T; He X
    Technol Cancer Res Treat; 2020; 19():1533033820962089. PubMed ID: 32964812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
    Jin LX; Moley JF
    Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic Risk Profile of Microscopic Lymphatic and Venous Invasion in Medullary Thyroid Cancer.
    Machens A; Lorenz K; Weber F; Dralle H
    Horm Metab Res; 2021 Sep; 53(9):588-593. PubMed ID: 34496409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CALCITONIN SECRETORY INDEX AND UNSUSPECTED NODAL DISEASE IN MEDULLARY THYROID CARCINOMA.
    Filimon S; Payne RJ; Black MJ; Hier MP; Mlynarek AM; Forest VI; Tamilia M
    Endocr Pract; 2018 May; 24(5):460-467. PubMed ID: 29847167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
    Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
    Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medullary thyroid cancer: epidemiological pattern and factors contributing to recurrence and metastasis.
    Hamdy O; Awny S; Metwally IH
    Ann R Coll Surg Engl; 2020 Sep; 102(7):499-503. PubMed ID: 32233867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical lymph node metastases of medullary thyroid carcinoma: CT findings.
    Pombo F; Rodríguez E; Cao JI; Martínez-Isla C
    Eur Radiol; 1997; 7(1):99-101. PubMed ID: 9000407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skip metastases in thyroid cancer leaping the central lymph node compartment.
    Machens A; Holzhausen HJ; Dralle H
    Arch Surg; 2004 Jan; 139(1):43-5. PubMed ID: 14718274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
    Ye L; Zhou X; Lu J; Wang Y; Xie X; Zhang J
    J Clin Lab Anal; 2020 Jul; 34(7):e23278. PubMed ID: 32141647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis.
    Qu N; Shi RL; Lu ZW; Liao T; Wen D; Sun GH; Li DS; Ji QH
    Oncotarget; 2016 Oct; 7(40):65937-65945. PubMed ID: 27588396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.
    Torresan F; Cavedon E; Mian C; Iacobone M
    World J Surg; 2018 Feb; 42(2):367-375. PubMed ID: 29134313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of central lymph node dissection for papillary thyroid carcinoma in cN0 T1/T2].
    Zhao SY; Ma YH; Yin Z; Zhan XX; Cheng RC; Qian J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):105-109. PubMed ID: 29429179
    [No Abstract]   [Full Text] [Related]  

  • 18. Delphian lymph node metastasis is a novel indicator of tumor aggressiveness and poor prognosis in papillary thyroid cancer.
    Zhu Y; Lin J; Yan Y; Zheng K; Zhang H; Wu K; Kong L; Chen L; Chen X
    J Surg Oncol; 2021 Jun; 123(7):1521-1528. PubMed ID: 33713443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of nodal metastasis for primary and reoperative thyroid cancer.
    Machens A; Hinze R; Thomusch O; Dralle H
    World J Surg; 2002 Jan; 26(1):22-8. PubMed ID: 11898029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and significance of Delphian node metastasis in papillary thyroid cancer.
    Iyer NG; Kumar A; Nixon IJ; Patel SG; Ganly I; Tuttle RM; Shah JP; Shaha AR
    Ann Surg; 2011 May; 253(5):988-91. PubMed ID: 21372688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.